Research on microencapsulation to develop food and drug administration (FDA) packages for premarket notification (also called PMN or 510(k) approval) for tissue imaging markers, and initiate…

Ended Cooperative Agreement Awarded Last action

Contract number
NNJ16GU04A
Awardee
Awarding agency
Obligated
$1,955,755

Award facts

Contract value 100% obligated
$1,955,755.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 0 offers Basic Research
Pricing
Other
Place of performance
Bristow, VA 20136, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 11 $52,895
Other Administrative Action 10 $0
Other Administrative Action 9 $0
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Other Administrative Action 5 $0
Other Administrative Action 6 $0
Other Administrative Action 3 $0
Other Administrative Action 4 $963,988
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $938,872
Show all 12

About this award

The U.S. National Aeronautics and Space Administration (NASA) Johnson Space Center awarded a $1,955,755.46 cooperative agreement to Nuvue Therapeutics Inc., a small disadvantaged business, to conduct research on microencapsulation for the development of Food and Drug Administration (FDA) packages for premarket notification (510(k) approval) of tissue imaging markers and to initiate pre-clinical trials for the encapsulation of chemotherapeutic agents. The contract has no set-aside designation and is set to be completed by May 31, 2018.

Description

Research on microencapsulation to develop food and drug administration (FDA) packages for premarket notification (also called PMN or 510(k) approval) for tissue imaging markers, and initiate pre-clinical trials for the encapsulation of chemotherapeutic agents.

Quick answers

Who was awarded contract NNJ16GU04A?

NNJ16GU04A was awarded to Nuvue Therapeutics Inc. by Johnson Space Center (National Aeronautics and Space Administration) on May 27, 2016.

How much is contract NNJ16GU04A worth?

The government has obligated $1,955,755 on NNJ16GU04A.

Was contract NNJ16GU04A competed?

The extent of competition for NNJ16GU04A was full and open competition. The government received 0 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award